NURS FPX 8045 Assessment 7 Literature Review

• NURS FPX 8045 Assessment 7 Literature Review.

Literature Review: Aspects of the proposed QI Project that differentiate it from a Research Study

There is a broad literature review about the incidence, prevalence, and pathogenesis of Type II diabetes mellitus (T2D) in the global population, most notably in American culture. Limited research exists on the Problem of non-drug adherence in T2D patients and potential interventions (Foley et al., 2021).

• Effective Strategies to Improve Medication Adherence in Type II Diabetes Mellitus Patients

From the setting of a five-year data analysis on drug adherence for T2D patients, which I carried out under the intervention of my preceptor, there needs to be more clarity on the most proficient strategy to address this issue of non-drug adherence. Subsequently, this QI is rotated around addressing this challenge (Jensen et al., 2017). The journal articles to be operationalized in responding to this gap in literature have been searched using watchwords on the research gap and the PICOT question through electronic databases like PubMed, NCBI, and JSTOR.

The potential consequences of this QI project include creating awareness in the target T2D patient population that adherence to maintained medicines will offer a predominant estimate, clinical staff and physicians dealing with T2D patients will be better informed on the most proficient strategy to deal with their patients, and the mortality rates from T2D will decline significantly.

Topic Scope and Purpose

• Addressing Medication Non-Adherence in Type II Diabetes: Evidence-Based Interventions and Future Directions

This QI project is meant to review the literature about T2D patients. The literature will be reviewed and rotated around three (3) central themes. Each theme’s topic will mirror the literature gap regarding the medical facility where I am currently doing my Practicum and bring out a proof-based practice (EBP) review of potential interventions. The three themes will be part of the central argument and the target population (Jensen et al., 2017). An illustration of potential qualities and weaknesses will be deliberated, illuminating the counterarguments. A rebuttal and an analytical presentation of the recommendations will then be reached. This project will end in a proof-based end with future possibilities for T2D patients who are casualties of medication non-adherence.

Identification of the Problem: Practice Gap

My preceptor and I have seen that my facility practice gap is Type II diabetes patients with non-adherence to diabetic medication. My preceptor and I came to this determination after analyzing clinical data for the T2D patients in the facility for the past five years. Based on empirical data, we established a reliable non-drug adherence behavior among T2D patients (Foley et al., 2021). We also realized that the pattern of non-drug adherence had been a significant reason behind the unfortunate estimate among these T2D patients. The information gained and the findings realized will be instrumental in addressing the Problem of non-drug adherence in T2D patients at the facility where I will coordinate my Practicum (Jensen et al., 2017). This evaluation will be integral to my NURS FPX 8045 Assessment 7 Literature Review, providing a foundation for addressing non-adherence issues in diabetic patients.

Argument

• Theme 1: Facts and Figures about T2D in the Population

Diabetes type II Mellitus (T2D) affects a significant population; therefore, this condition is of great general health importance. At least 462 million individuals were living with T2D by 2017 on a global scale, which amounts to 6.28 of the total populace, which is significant (Khan et al., 2020). The most affected part of the population is individuals 70 years of age and above, who account for 22% of new cases of T2D annually. The least affected are individuals in a couple of places in the range of 15 to 49 years of age, who account for 4.4 percent of the cases (Khan et al., 2020).

NURS FPX 8045 Assessment 7 Literature Review

In the US, T2D has an estimated prevalence rate of 6059 individuals for each 100,000, which is significant (Khan et al., 2020). Fortunately, T2D can be tolerated, and if especially managed, many patients can always report a predominant visualization. That notwithstanding, a culture of medication non-adherence among T2D patients is a typical problem, and this affects 4 to 31 percent of the T2D patient population (Blackburn et al., 2013).

Many lives have been lost because of non-drug adherence habits among T2D patients at my site of Practicum, subsequently the prerequisite for a proof-based intervention to address this gap in the literature. This theme is essential to the research problem in this project because it is part of the intervention cycle to address this non-drug adherence problem among T2D patients at my practicum facility.

• Theme 2: Secondary Clinical Effects in T2D Patients

At the point when T2D is not diagnosed on time, clinical intervention is made, and the patients often face secondary clinical challenges. Despite the ideal diagnosis and early intervention, Rezaei et al. (2019) say 56 percent of the T2D patient population does not stand a chance to defeat the limits of secondary diseases because they do not adhere to suggested drugs. Medication adherence is a significant challenge across the ways of life and non-communicable infections. In the case of T2D, patients have a high predisposition to developing outrageous metabolic anomalies once they do not adhere to maintained regimens.

For example, Rezaei et al. (2019) say T2D patients who are ineffectively managed or do not take glucose-regulating drugs are inclined to hypertension. The increased glucose past the average level cannot be regulated into optimal ranges through homeostasis because these patients either do not discharge insulin chemicals in their Beta cells of the pancreas or the receptor cells for insulin may resist the emitted chemical. Hence, increased glucose concentration leads to turn assimilation, by which fluids accumulate in the body cells and tissues, leading to increased blood volume and, in this manner, hypertension (Foley et al., 2021).

Similarly, patients who do not adhere to medication in their T2D pathogenesis also risk developing Renal Kidney Disease because of the obliterated nephrons because of increased glomerular strain due to hypertension. Consequently, this theme of T2D discretionary infections interfaces with the problem announcement, and this will enlighten the possible intervention hereunder.

• Theme 3: Ignorance about proper management of T2D.

It focuses on the fact that most T2D patients must understand that managing this condition is fundamental for conveying a dominating theory. Embraced drugs are gigantic, yet these clinical interventions can be further developed through non-drug-based intervention models. Rezaei et al. (2019) argue that thinking about how T2D is leaned toward prevented over-treated and that it is equivalently better to redesign treatment models with non-therapeutic designs than otherwise.

One of the models to resolve this Problem combines eating fitting meals that are low in fats, potassium, and sodium. Patients should nearly eat food plans high in fiber, including yet not confined to grains, standard things, and vegetables. T2D patients should, in this manner, regard genuine action. A piece of these proactive undertakings can facilitate walking, phenomenal activity, bicycling, running, running, and swimming. Genuine improvement increases handling, isolates fats, and diminishes weight. Foley et al.

(2021) argue that T2D impacts something like 10% of people in the public eye; thus, weight improvement should be monitored energetically. In this extraordinary situation, this theme of proper management of the T2D affliction in the affected people is accompanied by the problem explanation in this undertaking since it watches out for how to stay aware of ideal glycaemic control for most T2D patients. In addition, Polonsky and Henry (2016) say that settling the issue of glycaemic levels through eating less awful quality food, genuine turn of events, and lifestyle makes it possible to control T2D in everybody.

Counterarguments

• Addressing Non-Drug Adherence in Type II Diabetes Patients: Key Predictors and Interventions

Contrary to the management considered T2D patients, Al-Qerem et al. (2021) argue that adherence to embraced drugs is exclusively fundamental. In actuality, considering the way that metabolic changes in minutes can impel rout in diabetic patients, Al-Qerem et al. (2021) conflict with the probability that counting calories, certifiable movement, and lifestyle should in any way displace the discipline of adherence to steady in T2D patient masses.

NURS FPX 8045 Assessment 7 Literature Review

This counterargument is vital since it will offer an understanding of the intervention at my practicum place and genuinely focus on endeavors to resolve non-drug adherence. Furthermore, there is an opening mature adequate in the theme of discretionary clinical effects of T2D, considering that diabetes alone is satisfactory for hurting patients (Foley et al., 2021). Hence, there is a need to store each clinical resource and pool them to see on-drug adherence in the T2D country for a convincing intervention model.

Rebuttal: Intervention to Resolve the Problem

Considering the making review, change should address the opening implied. Picking Predictors of non-adherence to T2D drugs among Patients is a conclusive strategy to address the opening at my practicum place and toPracticuml region the fundamental of miserable figures due to non-drug adherence among these T2D patients (Foley et al., 2021). It is judicious to see the predictors of non-adherence to T2D drugs for individual patients, particularly the occasion of gatherings of patients. Therefore, when these predictors are seen as combat, Al-Qerem et al. (2021) will be fundamental and possibly able to resolve the Problem of medical non-adherence.

• The Role of Socioeconomic and Demographic Factors in T2D Drug Adherence

There are factors related to gatherings and individuals among the to-reliable non-adherence people inside the T2D public. A depiction of the factors that impact gatherings of individuals integrates a lack of impression of how disastrous T2D can become when adherence to suggested drugs is not verifiably followed (Foley et al., 2021). A nonattendance of information about the new movement in minutes should indicate to doctors that such an individual or group of T2D patients are led to non-drug adherence.

Another factor is the social and financial status of a patient. Al-Qerem et al. (2021) say most patients who come from accomplished monetary establishments and individuals who have compromised social affiliations are leaned to non-adherence to T2D drugs. Finally, looking at each patient’s age is central since this factor matters in the adherence to prescriptions or lack thereof. For sure, Al-Qerem et al. (2021) say that energetic adults are almost 100% more likely to adhere to suggested drugs than adults.

Recommendations and Conclusions

Doctors should perform enlightening tasks to educate T2D patients about the significant effects of this condition on body physiology, especially within minutes. Patients should organize these activities to understand the importance of adhering to prescribed medications. The government should play a fundamental role in assisting individuals and families struggling financially by providing support for essentials like education, food, shelter, clothing, and healthcare.

It is incredibly challenging for individuals who lack access to basic necessities to adhere to the strict regimens required for T2D management. Addressing the mental, emotional, social, and other clinical needs of T2D patients can better position them to stick to their medications and achieve better long-term outcomes. This insight is particularly relevant in the context of NURS FPX 8045 Assessment 7 Literature Review, which emphasizes the significance of holistic interventions for improving patient adherence and outcomes. Read more about our sample NURS FPX 8045 Assessment 3 Differentiate a QI/PI Project from a Research Study for complete information about this class.

References

Al-Qerem, W., Jarab, A. S., Badinjki, M., Hyassat, D., & Qarqaz, R. (2021). Exploring variables associated with medication non-adherence in patients with type 2 diabetes mellitus. PLoS ONE, 16(8).

https://doi.org/10.1371/journal.pone.0256666

Blackburn, D. F., Swidrovich, J., & Lemstra, M. (2013). Non-adherence in type 2 diabetes: Practical considerations for interpreting the literature. Patient Preference and Adherence, 7, 183–189.

https://doi.org/10.2147/PPA.S30613

Foley, L., Larkin, J., Lombard-Vance, R., Murphy, A. W., Hynes, L., Galvin, E., & Molloy, G. J. (2021). Prevalence and predictors of medication non-adherence among people living with multimorbidity: A systematic review and meta-analysis. BMJ Open, 11(9).

https://doi.org/10.1136/bmjopen-2020-044987

Jensen, M. L., Jørgensen, M. E., Hansen, E. H., Aagaard, L., & Carstensen, B. (2017). Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation. PLoS ONE, 12(6).

https://doi.org/10.1371/journal.pone.0179546

Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Kaabi, J. Al. (2020). Epidemiology of Type 2 diabetes – Global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107–111.

https://doi.org/10.2991/JEGH.K.191028.001

Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 10, 1299–1306.

https://doi.org/10.2147/PPA.S106821

Rezaei, M., Valiee, S., Tahan, M., Ebtekar, F., & Gheshlagh, R. G. (2019). Barriers of medication

adherence in patients with type-2 diabetes: A pilot qualitative study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 589–599.

https://doi.org/10.2147/DMSO.S197159